lisocabtagene maraleucel
bms
['mantle,(-dismantle)', 'lymphoma', 'nhl 001', 'transcend,nhl,001', 'nhl', 'liso-cel']
transcend nhl 001
liso-cel for mantle cell lymphoma #17icml - 88 pts - median 3 prior lines
- 94% prior btki
- 23% tp53mut
- 8% cns disease 
haematology registrar | @harvardmed fellow @PORTAL_research | evidence-based medicine & policy | lymphoma | myeloma | Fulbright | writer | SoMe Ed @BrJHaem